CompuGroup Medical US announces CEO transition   Austin, TX – Underlining the commitment to its second largest market worldwide by revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025. Benedikt Brueckle is a respected and experienced leader in the healt [ … ]

CGM plans to double its dividend Koblenz. The general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend to a higher level, and will therefore propose a dividend of EUR 1.00 per share to the Annual General Meeting for the financial year 2023. Based on the 52.2 million shares currently entitled to a d [ … ]

General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase Against the background of the stable financial and earnings position the general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend payment to a higher level. Therefore, the general partner plans to propose to the Annual  [ … ]

CGM drives digitization in the healthcare sector and significantly increases revenues and operating profit margin Group revenues increase by 5% to EUR 1.19 billion in 2023 Organic growth of 4.3% (5.3% ex TI) compared to strong previous year Share of recurring revenue climbs to new high of 69% Adjusted EBITDA increases by 13% to EUR 265 millio [ … ]

E-prescriptions new standard in Germany: CGM with positive interim assessment   Koblenz. In the first four weeks of this year, around 12 million e-prescriptions were issued in the German ambulatory information systems of CompuGroup Medical (CGM) alone. This means more e-prescriptions than redeemed overall in Germany between July 2021 and early De [ … ]